Literature DB >> 27639381

Regulation of antibody effector functions through IgG Fc N-glycosylation.

Isaak Quast1, Benjamin Peschke1, Jan D Lünemann2.   

Abstract

Immunoglobulin gamma (IgG) antibodies are key effector proteins of the immune system. They recognize antigens with high specificity and are indispensable for immunological memory following pathogen exposure or vaccination. The constant, crystallizable fragment (Fc) of IgG molecules mediates antibody effector functions such as complement-dependent cytotoxicity, antibody-mediated cellular cytotoxicity, and antibody-dependent cell-mediated phagocytosis. These functions are regulated by a single N-linked, biantennary glycan of the heavy chain, which resides just below the hinge region, and the presence of specific sugar moieties on the glycan has profound implications on IgG effector functions. Emerging knowledge of how Fc glycans contribute to IgG structure and functions has opened new avenues for the therapeutic exploitation of defined antibody glycoforms in the treatment of cancer and autoimmune diseases. Here, we review recent advances in understanding proinflammatory IgG effector functions and their regulation by Fc glycans.

Entities:  

Keywords:  Antibody; Glycan; Glycobiology; Immunoglobulin; Immunology; Immunotherapy

Mesh:

Substances:

Year:  2016        PMID: 27639381     DOI: 10.1007/s00018-016-2366-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  99 in total

Review 1.  Structure and function relationships in IgA.

Authors:  J M Woof; M W Russell
Journal:  Mucosal Immunol       Date:  2011-09-21       Impact factor: 7.313

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

3.  Flexibility of human IgG subclasses.

Authors:  K H Roux; L Strelets; T E Michaelsen
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

4.  Identification of a receptor required for the anti-inflammatory activity of IVIG.

Authors:  Robert M Anthony; Fredrik Wermeling; Mikael C I Karlsson; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

Review 5.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

6.  Structural changes in the oligosaccharide moiety of human IgG with aging.

Authors:  K Shikata; T Yasuda; F Takeuchi; T Konishi; M Nakata; T Mizuochi
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

7.  Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity.

Authors:  R B Parekh; I M Roitt; D A Isenberg; R A Dwek; B M Ansell; T W Rademacher
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

8.  BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway.

Authors:  Egest J Pone; Jinsong Zhang; Thach Mai; Clayton A White; Guideng Li; John K Sakakura; Pina J Patel; Ahmed Al-Qahtani; Hong Zan; Zhenming Xu; Paolo Casali
Journal:  Nat Commun       Date:  2012-04-03       Impact factor: 14.919

9.  Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.

Authors:  Manfred Wuhrer; Maurice H J Selman; Liam A McDonnell; Tania Kümpfel; Tobias Derfuss; Mohsen Khademi; Tomas Olsson; Reinhard Hohlfeld; Edgar Meinl; Markus Krumbholz
Journal:  J Neuroinflammation       Date:  2015-12-18       Impact factor: 8.322

10.  Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome.

Authors:  Frano Vučković; Jasminka Krištić; Ivan Gudelj; Maria Teruel; Toma Keser; Marija Pezer; Maja Pučić-Baković; Jerko Štambuk; Irena Trbojević-Akmačić; Clara Barrios; Tamara Pavić; Cristina Menni; Youxin Wang; Yong Zhou; Liufu Cui; Haicheng Song; Qiang Zeng; Xiuhua Guo; Bernardo A Pons-Estel; Paul McKeigue; Alan Leslie Patrick; Olga Gornik; Tim D Spector; Miroslav Harjaček; Marta Alarcon-Riquelme; Mariam Molokhia; Wei Wang; Gordan Lauc
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

View more
  17 in total

1.  The Rapidly Expanding Nexus of Immunoglobulin G N-Glycomics, Suboptimal Health Status, and Precision Medicine.

Authors:  Alyce Russell; Wei Wang
Journal:  Exp Suppl       Date:  2021

2.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

3.  The investigation of immunomodulatory activities of Gloeostereum incaratum polysaccharides in cyclophosphamide-induced immunosuppression mice.

Authors:  Di Wang; Qian Li; Yidi Qu; Mengya Wang; Lanzhou Li; Yang Liu; Yu Li
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

4.  Methotrexate Reduces the Clearance of Adalimumab by Increasing the Concentration of Neonatal Fc Receptor in Tissues.

Authors:  Yuwei Deng; Lixiong Liu; Wei Qiang; Li Hu; Lei Wang; Zeneng Cheng
Journal:  Pharm Res       Date:  2019-09-06       Impact factor: 4.200

5.  GlycA, a marker of protein glycosylation, is related to albuminuria and estimated glomerular filtration rate: the ELSA-Brasil study.

Authors:  Silvia M Titan; Roberto Pecoits-Filho; Sandhi M Barreto; Antônio Alberto Lopes; Isabela J Bensenor; Paulo A Lotufo
Journal:  BMC Nephrol       Date:  2017-12-20       Impact factor: 2.388

6.  Comparative N-Glycosylation Analysis of the Fc Portions of a Chimeric Human Coagulation Factor VIII and Immunoglobulin G1.

Authors:  Christoph Kannicht; Mario Kröning; Barbara A Solecka-Witulska; Guido Kohla; Julia Rosenlöcher
Journal:  Bioengineering (Basel)       Date:  2017-05-17

Review 7.  Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.

Authors:  Wei Li; Zhongyu Zhu; Weizao Chen; Yang Feng; Dimiter S Dimitrov
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

8.  Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients.

Authors:  Xiaoli Zeng; Siting Li; Shiyi Tang; Xi Li; Guoyuan Zhang; Mengtao Li; Xiaofeng Zeng; Chaojun Hu
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

Review 9.  Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised Medicine.

Authors:  Alyce Russell; Eric Adua; Ivo Ugrina; Simon Laws; Wei Wang
Journal:  Int J Mol Sci       Date:  2018-01-29       Impact factor: 5.923

10.  Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S.

Authors:  Beatriz Trastoy; Erik Klontz; Jared Orwenyo; Alberto Marina; Lai-Xi Wang; Eric J Sundberg; Marcelo E Guerin
Journal:  Nat Commun       Date:  2018-05-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.